U.S. market projected to grow from USD 2.45 billion in 2025 to USD 5.01 billion by 2035, while Europe is forecast to reach USD 4.02 billion amid rising adoption of transdermal therapeutics and vaccine ...
Controlled drug delivery systems based on in situ forming implants offer a versatile platform for achieving sustained and localised therapeutic release from a single administration. These systems ...
A recent study published in Nature Communications showcased a breakthrough in transdermal drug delivery. Scientists have developed an electrically activated patch with biocompatible metallic membranes ...
The review highlights nanocarriers, microspheres, hydrogels, microneedles, long-acting formulations, and co-formulations as ...
A team of scientists has developed grain-sized soft robots that can be controlled using magnetic fields for targeted drug delivery, paving the way to possible improved therapies in future. A team of ...
Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...
Aug. 26 (UPI) --The Food and Drug Administration on Monday approved Insulet's Omnipod 5 automated insulin delivery system for people with Type 2 diabetes. In 2022, the FDA signed off on the system for ...
Lung cancer remains one of the world's deadliest cancers, yet despite decades of effort to develop new drugs, many fail because they don't stay in the body long enough to be effective or because they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results